These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 19155773)

  • 1. European Society of Hypertension Working Group on Obesity Obesity-induced hypertension and target organ damage: current knowledge and future directions.
    Schlaich MP; Grassi G; Lambert GW; Straznicky N; Esler MD; Dixon J; Lambert EA; Redon J; Narkiewicz K; Jordan J; ;
    J Hypertens; 2009 Feb; 27(2):207-11. PubMed ID: 19155773
    [No Abstract]   [Full Text] [Related]  

  • 2. Mineralocorticoid receptor activation in obesity hypertension.
    Nagase M; Fujita T
    Hypertens Res; 2009 Aug; 32(8):649-57. PubMed ID: 19521418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of obesity on cardiovascular disease.
    Zalesin KC; Franklin BA; Miller WM; Peterson ED; McCullough PA
    Endocrinol Metab Clin North Am; 2008 Sep; 37(3):663-84, ix. PubMed ID: 18775358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gross obesity; the cardiovascular consequences.
    Alexander JK
    Minn Med; 1969 Aug; 52(8):1289-91. PubMed ID: 5804999
    [No Abstract]   [Full Text] [Related]  

  • 5. [Aging and senescence in the development of hypertensive target-organ damage].
    Nakahashi T; Morimoto S; Matsumoto M
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():51-5. PubMed ID: 15171340
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular complications of obesity.
    Alexander JK
    Cardiovasc Nurs; 1969; 5(5):19-21. PubMed ID: 5194965
    [No Abstract]   [Full Text] [Related]  

  • 7. Chronic heart disease due to obesity.
    Alexander JK
    J Chronic Dis; 1965 Sep; 18(9):895-8. PubMed ID: 4220542
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cardiovascular complications in obesity].
    Dincheva K
    Vutr Boles; 1982; 21(4):7-12. PubMed ID: 6755911
    [No Abstract]   [Full Text] [Related]  

  • 9. [Over-weight as risk factor with special regard to hypertension, arteriosclerosis and gout].
    Schollmeyer P
    Z Allgemeinmed; 1972 Oct; 48(29):1342-5. PubMed ID: 4636977
    [No Abstract]   [Full Text] [Related]  

  • 10. European Society of Hypertension Working Group on Obesity: background, aims and perspectives.
    Jordan J; Engeli S; Redon J; Sharma AM; Luft FC; Narkiewicz K; Grassi G;
    J Hypertens; 2007 Apr; 25(4):897-900. PubMed ID: 17351387
    [No Abstract]   [Full Text] [Related]  

  • 11. Obesity, hypertension, and the heart.
    Good D; Morse SA; Ventura HO; Reisin E
    J Cardiometab Syndr; 2008; 3(3):168-72. PubMed ID: 18983334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Albuminuria in heart failure: what do we really know?
    Dobre D; Nimade S; de Zeeuw D
    Curr Opin Cardiol; 2009 Mar; 24(2):148-54. PubMed ID: 19532101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Obesity and cardiovascular diseases].
    Kobusiak-Prokopowicz M
    Pol Merkur Lekarski; 1999 Dec; 7(42):279-82. PubMed ID: 10710955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Behavior of the cardiovascular system during radium therapy of genital neoplasms].
    Brina A; Lo Cicero G
    Ann Ostet Ginecol Med Perinat; 1968 Dec; 90(12):825-42. PubMed ID: 5730907
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk factors and hypertension.
    Hames CG; Heyden S
    J Med Assoc Ga; 1981 May; 70(5):337-8. PubMed ID: 7264465
    [No Abstract]   [Full Text] [Related]  

  • 16. Heart remodelling and obesity: the complexities and variation of cardiac geometry.
    Ashrafian H; Athanasiou T; le Roux CW
    Heart; 2011 Feb; 97(3):171-2. PubMed ID: 21189309
    [No Abstract]   [Full Text] [Related]  

  • 17. Reverse epidemiology in systolic and nonsystolic heart failure: cumulative prognostic benefit of classical cardiovascular risk factors.
    Güder G; Frantz S; Bauersachs J; Allolio B; Wanner C; Koller MT; Ertl G; Angermann CE; Störk S
    Circ Heart Fail; 2009 Nov; 2(6):563-71. PubMed ID: 19919981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress and inflammation in obesity, diabetes, hypertension, and related cardiometabolic complications.
    Ndisang JF; Vannacci A; Rastogi S
    Oxid Med Cell Longev; 2014; 2014():506948. PubMed ID: 24723993
    [No Abstract]   [Full Text] [Related]  

  • 19. Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in obesity-induced hypertension.
    Nagae A; Fujita M; Kawarazaki H; Matsui H; Ando K; Fujita T
    Circulation; 2009 Feb; 119(7):978-86. PubMed ID: 19204299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inflammation, oxidative stress and kidney function in arterial hypertension].
    Cerasola G; Guarneri M; Cottone S
    G Ital Nefrol; 2009; 26 Suppl 46():8-13. PubMed ID: 19644813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.